OBITUARY
FACE-DOWN POSTURING AFTER MACULAR HOLE SURGERY
25-GAUGE SUTURELESS VITRECTOMY VERSUS 20-GAUGE VITRECTOMY FOR THE REPAIR OF PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT
25-GAUGE SUTURELESS VITRECTOMY
RISK FACTORS ASSOCIATED WITH SCLEROTOMY LEAKAGE AND POSTOPERATIVE HYPOTONY AFTER 23-GAUGE TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY
LONG-TERM FOLLOW-UP OF VITRECTOMY FOR DIFFUSE NONTRACTIONAL DIABETIC MACULAR EDEMA
SUPRACHOROIDAL HEMORRHAGE DURING PARS PLANA VITRECTOMY IN TRAUMATIZED EYES
SURGICALLY-INDUCED INFLAMMATION WITH 20-, 23-, AND 25-GAUGE VITRECTOMY SYSTEMS
PASCAL DYNAMIC CONTOUR TONOMETRY VERSUS GOLDMANN APPLANATION TONOMETRY IN GAS AND AIR-FILLED EYES AFTER VITRECTOMY SURGERY
REFRACTIVE OUTCOMES OF PHACOEMULSIFICATION AND INTRAOCULAR LENS IMPLANTATION AFTER PARS PLANA VITRECTOMY
DYE EXTRUSION TECHNIQUE (DE-TECH)
PRECLINICAL INVESTIGATION OF THE RETINAL BIOCOMPATIBILITY OF SIX NOVEL VITAL DYES FOR CHROMOVITRECTOMY
BEVACIZUMAB COMPARED WITH MACULAR LASER GRID PHOTOCOAGULATION FOR CYSTOID MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION
PANRETINAL PHOTOCOAGULATION COMBINED WITH INTRAVITREAL BEVACIZUMAB IN HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
CONCENTRATION OF CYTOKINES IN THE AQUEOUS HUMOR OF PATIENTS WITH NAIVE, RECURRENT AND REGRESSED CNV ASSOCIATED WITH AMD AFTER BEVACIZUMAB TREATMENT
PREVENTION OF VISION LOSS AFTER CATARACT SURGERY IN DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB
INTRAVITREAL RANIBIZUMAB, INTRAVITREAL RANIBIZUMAB WITH PDT, AND INTRAVITREAL TRIAMCINOLONE WITH PDT FOR THE TREATMENT OF RETINAL ANGIOMATOUS PROLIFERATION
CLINICAL FEATURES AND SURGICAL OUTCOMES OF PEDIATRIC RHEGMATOGENOUS RETINAL DETACHMENT
An Alternative Method of Extraction: Use of a Catheter to Remove Intraocular Foreign Bodies During Vitrectomy
Diagnostic and Therapeutic Challenges
A Head-Tilt Test for Hypopyon After Intravitreal Triamcinolone
Correspondence
Reply
Correspondence
Reply